748
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Squamous cell carcinoma of the scalp: a combination of different therapeutic strategies

, ORCID Icon, ORCID Icon, , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Article: 2210670 | Received 13 Mar 2023, Accepted 02 May 2023, Published online: 12 May 2023

References

  • Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 2. Treatment. Eur J Cancer. 2020; 128:83–102. Epub 2020 Feb 26. PMID: 32113942.
  • Claveau J, Archambault J, Ernst DS, et al. Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma. Current Oncology. 2020;27(4):399–407.
  • Schaffer M, Simonovich A, Livof A, et al. Use of cemiplimab in locally advanced cutaneous squamous cell carcinoma. Clin Case Rep. 2020;10:1–4.
  • Trignano E, Fallico N, Nitto A, et al. The treatment of composite defect of bone and soft tissues with a combined latissimus dorsi and serratus anterior and rib free flap. Microsurgery. 2013;33(3):173–183. Epub 2013 Feb 25. PMID: 23436310.
  • Chen HC, Fallico N, Ciudad P, et al. Latissimus dorsi-rib pedicle flap for mandibular reconstruction as a salvage procedure for failed free fibula flap. J Craniofac Surg. 2014;25(3):961–963. PMID: 24777023.
  • Trignano E, Fallico N, Fiorot L, et al. Flap monitoring with continuous oxygen partial tension measurement in breast reconstructive surgery: a preliminary report. Microsurgery. 2018;38(4):402–406. Epub 2017 Nov 13. PMID: 29131393.
  • Trignano E, Dessy LA, Fallico N, et al. Treatment of pectoralis major flap myospasms with botulinum toxin type a in head and neck reconstruction. J Plast Reconstr Aesthet Surg. 2012; 65(2):e23-8–e28. Epub 2011 Nov 9. PMID: 22071458.
  • Migden MR, Khushalani NI, Chang ALS, et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol. 2020; 21(2):294–305.
  • Tanvetyanon T, Padhya T, McCaffrey J, et al. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2015;37(6):840–845.
  • Ahmed SR, Petersen E, Patel R, et al. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma. Expert Rev Clin Pharmacol. 2019;12(10):947–951.
  • Wang JT, Palme CE, Morgan GJ, et al. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2012;34(11):1524–1528.
  • Givi B, Andersen PE, Diggs BS, et al. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2011;33(7):999–1004.
  • Gruber I, Koelbl O. Dramatic radiotherapy response of a giant T4 cutaneous squamous cell carcinoma of the scalp with extensive bone destruction: a case report. J Med Case Reports. 2021;15(1):610.
  • Likhacheva A, Awan M, Barker CA, et al. Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American society for radiation oncology clinical practice guideline. Pract Radiat Oncol. 2020;10(1):8–20.